share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H

禮來 | 4:持股變動聲明-董事 JOHNSON KIMBERLY H
美股SEC公告 ·  09/18 05:18

牛牛AI助理已提取核心訊息

On September 16, 2024, Kimberly H. Johnson, associated with Eli Lilly and Co (LLY), completed a purchase of 10 shares of common stock at a price of $923.54 per share. Following this transaction, Johnson's direct holdings in the company increased to a total of 2,688 shares. The transaction, which was conducted in USD, is part of a grant, award, or other acquisition, as per the transaction code description. This investment move could signal confidence in the pharmaceutical company's future prospects.
On September 16, 2024, Kimberly H. Johnson, associated with Eli Lilly and Co (LLY), completed a purchase of 10 shares of common stock at a price of $923.54 per share. Following this transaction, Johnson's direct holdings in the company increased to a total of 2,688 shares. The transaction, which was conducted in USD, is part of a grant, award, or other acquisition, as per the transaction code description. This investment move could signal confidence in the pharmaceutical company's future prospects.
2024年9月16日,與禮來公司(LLY)有關的Kimberly H. Johnson以每股923.54美元的價格購買了10股普通股。在此次交易之後,Johnson在該公司的直接持股增加到了總共2,688股。此交易是作爲授予、獎勵或其他獲取方式的一部分,根據交易代碼描述。這一投資舉動可能預示着對該藥品公司未來前景的信心。
2024年9月16日,與禮來公司(LLY)有關的Kimberly H. Johnson以每股923.54美元的價格購買了10股普通股。在此次交易之後,Johnson在該公司的直接持股增加到了總共2,688股。此交易是作爲授予、獎勵或其他獲取方式的一部分,根據交易代碼描述。這一投資舉動可能預示着對該藥品公司未來前景的信心。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。